Associate Director Forecasting & Valuation, Portfolio Strategy

About the role

Define and drive the forecasting and valuation strategy, roadmap, standards and governance framework to support Immunocore's portfolio and corporate objectives. Serve as internal subject matter expert and adviser for forecasting, valuation and portfolio analytics.

Vacancy No VN885 • Full Time • Oxford, UK • Department: Development Strategy

Responsibilities

• Develop and build patient-based forecasts and DCF valuation models to support investment decisions and company valuation
• Triangulate data from multiple primary and secondary sources to develop holistic package of baseline assumptions for asset valuation, resolving conflicting evidence and exercising independent judgement where data is limited or ambiguous
• Build patient-based revenue forecasts and DCF valuation models for pipeline assets, selecting and, where required, creating fit-for-purpose modelling approaches
• Proactively build trusted partnerships with key business partners across development, clinical, finance, commercial and business development; influence, negotiate and build alignment among senior cross-functional stakeholders where assumptions, evidence or valuation conclusions are complex, uncertain or contested
• Develop sensitivity and scenario analyses to characterise key forecast drivers and key risks for senior leadership
• Develop clear summaries of model outputs, conclusions and implications for decision making and present to senior leadership
• Drive delivery of the corporate valuation, ensuring assumptions are robust, well-evidenced and clearly documented
• Support Investor Relations with guidance on sales forecasts for external communication
• Inform company-level strategy through forecasting and valuation insight
• Lead complex cross-functional forecasting, valuation and portfolio planning initiatives, coordinating senior stakeholders and driving alignment on key business decisions
• Develop comparative valuation analyses that position Immunocore’s portfolio against competitors to inform portfolio decisions and the external valuation narrative
• Apply valuation metrics in portfolio-level scenario planning, quantifying the trade-offs between investment options to inform prioritisation and resource allocation decisions
• Support Business Development by valuing licensing and partnering opportunities and outlining key sensitivities
• Establish and maintain best-practice methodologies, governance and quality standards for forecasting and valuation activities
• Lead the continued evolution of the forecasting and valuation platform, improving the approach and tools, in line with the agreed analytics strategy
• Identify, evaluate and implement AI and other novel tools and data sources to build more complex models in less time, improve forecast accuracy and automate routine analyses, freeing capacity for higher-value strategic work
• Act as internal champion for forecasting and valuation methods — validating outputs, defining where AI-assisted analysis is and is not appropriate, building stakeholder confidence in the results, and sharing best practice with colleagues across Portfolio Strategy and partner functions
• Inform portfolio strategy projects and deliver CI insights to drive strategy decisions for pipeline products, as required
• Scope and deliver market opportunity assessments for pipeline assets and / or new indications
• Synthesise competitor and clinical data to define current and potential future treatment landscape and clearly identify implications for Immunocore
• Develop and present recommendations to senior leadership on Immunocore’s R&D pipeline, TPP requirements and cross-portfolio strategy decisions to directly influence portfolio prioritisation